The Alabama pharmaceutical manufacturing plant is set to increase its workforce by 2,500, the company announced on Tuesday.
The company announced the expansion in a press release, saying it was a direct result of the state’s recent approval of the biotechnology company, Aurobindo, for the production of pharmaceuticals.
Aurobindos initial patent for the technology was awarded in 2017.
The company will also expand its research and development efforts.
The announcement came on the heels of a state court ruling that cleared the way for Aurobids approval in Alabama, which is one of the most expensive states in the nation for manufacturing pharmaceuticals and related products.
The state of Alabama has the second highest rate of prescription drug overdose deaths in the country.
Last year, the state recorded 2,788 overdose deaths.
More: Alabama has a total of 4,764 deaths per 100,000 residents.